- Credit Hours: 3 Hours
- Author: John Tinsley
- Price: $39.00
Learning Objectives
Upon completion of this course, participants will be able to:
• Identify the vulnerable populations that require specialized treatment considerations for stimulant use disorders, including women, adolescents, LGBTQ+ individuals, and people experiencing homelessness.
• Describe how racial and ethnic health disparities affect access to and engagement in treatment for stimulant use disorders.
• Explain the unique treatment considerations for pregnant women with stimulant use disorders.
• Analyze the treatment needs of individuals with co-occurring stimulant use disorders and HIV/AIDS, hepatitis, or other infectious diseases.
• Describe adaptations needed for treating stimulant use disorders in criminal justice populations and rural communities.
• Explain how treatment approaches should be modified for individuals taking medication for opioid use disorder who also have stimulant use disorders.
Package Contents
Course Update
About the Instructor
John Tinsley
Dr. John H. Tinsley is a former assistant professor of Medical Physiology at the Texas A&M University System College of Medicine. He received his Ph.D. from Texas A&M University, College Station, Texas; M.S. from the University of North Carolina; and his B.S. from the University of Oklahoma.
He has been teaching, training, consulting and conducting research in the fields of Medical Physiology and Behavioral Biology for over twenty-nine years. Dr. Tinsley has authored over twenty-five professional and refereed articles, including invited reviews. He has been a member of the American Society for Physiology, and work done in 2001 led to an international award from The European Society on Microcirculation. Dr. Tinsley has received research funding from the Veteran’s Administration, American Heart Association, and Scott and White Hospital. In addition, he has served on numerous review committees for national grant-funding agencies and scientific journals.
Approved and Widely Recognized
CEU Matrix is approved by the following national and state accreditation boards:
CEU Matrix is approved with the following state boards:
Arkansas (ASACB), California (CCAPP #OS-07-394-0222), California (CADTP #250), Connecticut (#0115-5202), Delaware (DCB #37), Florida (FCB #5141-A), Georgia (ADACBGA #2026-4-003), Illinois (IAODAPCA #19345), Kentucky, Louisiana (LA ADRA #E026), Michigan (MCBAP), Missouri (Missouri CB #183), New Mexico (NMCBBHP #2046), North Carolina (NCSAPPB), Ohio (OCDP #50-19236), Oklahoma (OBLADS #20260153), Texas (TCB #1758-07)
